BEXSERO
Glaxosmithkline Biologicals S.A.
Application Filed: 2011-09-22
Trademark Application Details
SECTION 71 ACCEPTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79104116 |
| Registration Number | 4130376 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Domestic Representative | Angela L. Wilson |
| Attorney Name | Angela L. Wilson |
| Attorney Docket Number | 81239304 |
| Law Office Assigned | M70 |
| Employee Name | BRECKENFELD, WILLIAM G |
Timeline
| 2011-09-22 | Application Filed |
| 2012-02-07 | Published for Opposition |
| 2012-04-24 | Trademark Registered |
| 2018-08-28 | Location: GENERIC WEB UPDATE |
| 2018-08-28 | Status: Live/Registered |
| 2018-08-28 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxosmithkline Biologicals S.A. |
| Address | Rue de l'Institut 89 Rixensart BE B-1330 |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260302 | Ovals, plain single line; Plain single line ovals |
| 260515 | Four or more triangles; Triangles |
| 260521 | Triangles that are completely or partially shaded |
| 260525 | Triangles with one or more curved sides |
| 260728 | Diamond shapes (miscellaneous overall shape); Miscellaneous designs with overall diamond shape, including letters forming or comprising a diamond |
| 260909 | Squares made of geometric figures, objects, humans, plants or animals |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | The color(s) black, orange, and blue is/are claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2011-11-10 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2011-11-15 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2011-11-19 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2011-11-30 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2011-12-02 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2011-12-03 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2011-12-05 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2011-12-05 | 8 RFCS P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2011-12-08 | 9 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-12-08 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-12-08 | 11 TEME I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2011-12-08 | 12 TCCA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-12-12 | 13 CNSA O:Outgoing Correspondence |
| REFUSAL PROCESSED BY IB | 2011-12-24 | 14 RFNT P: |
| ASSIGNED TO LIE | 2011-12-30 | 15 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-12-31 | 16 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2012-01-18 | 17 NPUB O:Outgoing Correspondence |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2012-01-18 | 18 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2012-01-18 | 19 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2012-02-07 | 20 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2012-04-24 | 21 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2012-07-24 | 22 FICR P: |
| FINAL DISPOSITION PROCESSED | 2012-08-03 | 23 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2012-08-03 | 24 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2012-08-29 | 25 FINV P: |
| NOTIFICATION PROCESSED BY IB | 2012-11-18 | 26 GPNX P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2013-04-28 | 27 NREP P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2015-07-03 | 28 CHLD M: |
| TEAS SECTION 71 RECEIVED | 2018-08-15 | 29 ES71 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2018-08-28 | 30 APRE A:Allowance for Publication |
| REGISTERED-SEC.71 ACCEPTED | 2018-08-28 | 31 71AG O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | 2018-08-28 | 32 NA71 E:E-Mail |
| COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | 2021-04-24 | 33 REM4 E:E-Mail |
| TEAS SECTION 71 RECEIVED | 2021-09-01 | 34 ES71 I:Incoming Correspondence |
| INTERNATIONAL REGISTRATION RENEWED | 2021-10-08 | 35 RNWL P: |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-04-08 | 36 APRE A:Allowance for Publication |
| POST REGISTRATION ACTION MAILED - SEC.71 | 2022-04-08 | 37 PR71 O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-08-02 | 38 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-08-02 | 39 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2022-08-02 | 40 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-08-02 | 41 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | 2022-10-04 | 42 EROP I:Incoming Correspondence |
| POST REGISTRATION ACTION MAILED - SEC.71 | 2022-10-06 | 43 PR71 O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | 2022-10-07 | 44 EROP I:Incoming Correspondence |
| REGISTERED-SEC.71 ACCEPTED | 2022-10-11 | 45 71AG O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | 2022-10-11 | 46 NA71 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BEXSERO 79104116 4130376 Live/Registered |
Glaxosmithkline Biologicals S.A. 2011-09-22 |
 BEXSERO 77896927 3821791 Live/Registered |
GLAXOSMITHKLINE BIOLOGICALS S.A. 2009-12-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 